Search research articles
Contact Us
Filters
Showing results (51-60 of 90) with videos related to
Page
of 9
Sort By:
Biorxiv : the Preprint Server for Biology
|
July 19, 2024
HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapy
Nicolas M S Galvez, Yi Cao, Adam D Nitido, et al.
Science Translational Medicine
|
August 19, 2021
Blocking α<sub>4</sub>β<sub>7</sub> integrin delays viral rebound in SHIV<sub>SF162P3</sub>-infected macaques treated with anti-HIV broadly neutralizing antibodies
Ines Frank, Mariasole Cigoli, Muhammad S Arif, et al.
Nature Medicine
|
March 22, 2016
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques
Ann J Hessell, J Pablo Jaworski, Erin Epson, et al.
Immunity
|
September 5, 2021
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
Laura A VanBlargan, Lucas J Adams, Zhuoming Liu, et al.
The New England Journal of Medicine
|
July 7, 2021
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
Venkata-Viswanadh Edara, Benjamin A Pinsky, Mehul S Suthar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2020
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
Mangaiarkarasi Asokan, Joana Dias, Cuiping Liu, et al.
Immunity
|
February 26, 2026
HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized mice
Nicolas M S Galvez, Adam D Nitido, Seo Bin Yoo, et al.
Cell Reports
|
April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base
Angela R Corrigan, Hongying Duan, Cheng Cheng, et al.
Scientific Reports
|
October 26, 2022
Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life
Baoshan Zhang, Deepika Gollapudi, Jason Gorman, et al.
Science Translational Medicine
|
September 8, 2017
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge
Boris Julg, Lawrence J Tartaglia, Brandon F Keele, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 90) with videos related to
Sort By:
Page
of 9
Biorxiv : the Preprint Server for Biology
|
July 19, 2024
HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapy
Nicolas M S Galvez, Yi Cao, Adam D Nitido, et al.
Science Translational Medicine
|
August 19, 2021
Blocking α<sub>4</sub>β<sub>7</sub> integrin delays viral rebound in SHIV<sub>SF162P3</sub>-infected macaques treated with anti-HIV broadly neutralizing antibodies
Ines Frank, Mariasole Cigoli, Muhammad S Arif, et al.
Nature Medicine
|
March 22, 2016
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques
Ann J Hessell, J Pablo Jaworski, Erin Epson, et al.
Immunity
|
September 5, 2021
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
Laura A VanBlargan, Lucas J Adams, Zhuoming Liu, et al.
The New England Journal of Medicine
|
July 7, 2021
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
Venkata-Viswanadh Edara, Benjamin A Pinsky, Mehul S Suthar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2020
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
Mangaiarkarasi Asokan, Joana Dias, Cuiping Liu, et al.
Immunity
|
February 26, 2026
HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized mice
Nicolas M S Galvez, Adam D Nitido, Seo Bin Yoo, et al.
Cell Reports
|
April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base
Angela R Corrigan, Hongying Duan, Cheng Cheng, et al.
Scientific Reports
|
October 26, 2022
Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life
Baoshan Zhang, Deepika Gollapudi, Jason Gorman, et al.
Science Translational Medicine
|
September 8, 2017
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge
Boris Julg, Lawrence J Tartaglia, Brandon F Keele, et al.
Page
of 9